All Clarivate websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.

More information on our cookie policy.

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
  • Special reports
    • Aging
    • Biosimilars
    • Artificial intelligence
    • Coronavirus
    • IVDs on the rise
    • Radiopharmaceuticals
    • Science '22 in Review
    • Top Biopharma Trends of 2022
    • Top Med-tech Trends of 2022
    • Premium reports
      • BioWorld Financings Reports
      • Disease Incidence & Prevalence Summaries

BioWorld. Link to homepage.

  • sign in
  • Sign Out
  • My Account
Subscribe
BioWorld - Wednesday, May 31, 2023
Home » Authors » Sharon Kingman

Sharon Kingman

Articles

ARTICLES

Study suggests T helper cells will be harnessed for immunotherapy

Dec. 31, 2014
By Sharon Kingman
No Comments
LONDON – T helper cells, which help to coordinate the immune response, do recognize mutations found in cancer cells, researchers have found. The discovery suggests that it may one day be possible to use T helper cells in cancer immunotherapy, by stimulating them to recognize specific tumors.
Read More

Molecule found in lung cancer cells could be new target

Dec. 24, 2014
By Sharon Kingman
No Comments
LONDON – Scientists reported that they have found an ideal drug target that could lead to a treatment for lung cancer. The study, by an international team of researchers, identified a molecule that is found in lung cancer cells but not in normal lung tissue.
Read More

Study points to daily injection for diabetes and obesity combined

Dec. 10, 2014
By Sharon Kingman
No Comments
LONDON – "Superdrugs" – single peptides containing several hormonal activities – could be available to treat diabetes and obesity within a few years, scientists suggest. One of those composite molecules has already shown promising results in rodent models of diabetes and obesity and could provide a medical alternative to gastric bypass surgery, the researchers said.
Read More

Gene therapy cures mice of cardiomyopathy

Dec. 5, 2014
By Sharon Kingman
No Comments
LONDON – Gene therapy for babies born with a rare, but severe type of inherited heart disease could become a realistic option in the future, scientists suggest, following successful prevention of disease in a related mouse model
Read More

Spaghetti junction controls molecular traffic to the nucleus

Nov. 26, 2014
By Sharon Kingman
No Comments
LONDON – One of the latest techniques for understanding the structure of the pores that control what can enter and leave cell nuclei involves poking and feeling the molecules inside the pores using a very, very tiny spike of silicon.
Read More

Influenza drug targets become crystal clear

Nov. 21, 2014
By Sharon Kingman
No Comments
LONDON – The knowledge of the exact structure of the enzyme that the influenza virus uses to make new influenza viruses will give a huge boost to the search for drugs to treat that infection, scientists predict.
Read More

SPHINX solves the riddle of how to block angiogenesis

Nov. 13, 2014
By Sharon Kingman
No Comments
LONDON – New drugs to treat cancer, which work by stopping the formation of new blood vessels in the tumor, are in the pipeline and could enter clinical trials within a few years.
Read More

Study reveals potential pathway for diabetes and obesity treatment

Nov. 5, 2014
By Sharon Kingman
No Comments
LONDON – Damping down a type of low-grade inflammation that occurs in adipose tissue – particularly in those who are obese – could be a way to control type 2 diabetes and obesity in the future, scientists said.
Read More

Huge spread of genes contributes to autism, study finds

Oct. 30, 2014
By Sharon Kingman
No Comments
LONDON – The discovery of more than 30 genes containing new mutations that are highly likely to play a role in the development of autism spectrum disorder (ASD) will provide new insights into the causes of these conditions.
Read More

New target could lead to drugs to stimulate bone formation

Oct. 22, 2014
By Sharon Kingman
No Comments
LONDON – New drugs that will help boost the density of bone in conditions such as osteoporosis could be developed as a result of a new understanding of how bone cells interact with each other. Researchers working in Germany have established how the hormone calcitonin regulates bone remodeling via a receptor found on bone cells.
Read More
View All Articles by Sharon Kingman

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for May 30, 2023.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for May 30, 2023.
  • FDA approved icons and medical professional

    Genmab, Abbvie to join Roche with FDA nod for CD20 bispecific in lymphoma

    BioWorld
    Five months after the first anti-CD20xCD3 T-cell engaging bispecific antibody, Roche Holding AG’s Lunsumio (mosunetuzumab), cleared U.S. FDA approval for...
  • Illustration of pancreas

    Gene therapy to reverse T2D shows proof of concept at ASGCT

    BioWorld
    The most ambitious objective of any treatment is to eradicate the disease, acting on its origin to cure it instead of treating its symptoms. This is the purpose...
  • Clinical data illustration

    Medtronic, Philips, Edwards late-breaking study data spotlighted at EuroPCR

    BioWorld MedTech
    Among the many companies presenting data at the EuroPCR conference in Paris, several late breaking trials from heavy hitters Medtronic plc, Royal Phillips NV and...
black cortellis ad

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

Subscribe
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • Patents
  • More
    • About
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
Follow Us

Copyright ©2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing